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06 IMMUNOTHERAPY AND IMMUNOMODULATION
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Introduction and Objectives: Our group have previously shown that KM+, a mannose-
binding lectin extracted from jack-fruit seeds (Artocarpus integrifolia), induced IL-12
production either in vitro or in vivo, and therefore was able to switch the cytokine profile
from Th2 (IL-4) to Th1 (IFN-γ), leading to the development of a protective Th1-type polarized
response against Leishmania major in BALB/c mice infection model (Glycobiology. 11:1035-
1042, 2001). Since resistance to P. brasiliensis infection correlates with efficient Th1 immune
response, we aimed to evaluate the interference of jfKM+ (KM+ extracted from jack fruit
seeds) administration as well as its recombinant counterpart (rKM+) in the course of
experimental paracoccidioidomycosis (PCM). Methods and Results: BALB/c mice were
divided into two experimental groups, according to the period of KM+ (0.5 µg) subcutaneous
administration: group I was injected with jfKM+/rKM+ 10 and 3 days before the intravenous
challenge with P. brasiliensis (1x106 yeasts of Pb18 isolate), whereas group II was injected
10 days after the challenge. Control groups received PBS instead of jfKM+/rKM+ or yeasts.
The animals were killed 14 and 30 days postinfection and several parameters were analyzed.
Mice from groups I and II, presented 86% less colony forming units (CFU) in lungs than the
non-treated control group. Moreover, histopathology of lung sections from these groups of
mice (I and II) revealed total absence or very few organized granulomas. Nevertheless, the
non-treated control group presented large and confluent granulomas involving extensive
areas of the lungs, with an inflammatory cellular infiltration and numerous budding yeast
cells, reflecting the CFU data. When we compared the pulmonary cytokines produced by
groups I and II with those produced by the non-treated control group we observed that lung
homogenates derived from both groups revealed a Th1 bias, with high NO production and
high levels of proinflamatory cytokines TNF-α, IL12 and IFN-γ, whereas the non-treated
control group, by contrast, presented substantial release of Th2-type cytokines such as IL-4
and IL-10. Conclusion: Taken together, our observations strengthen the view that jfKM+, as
well as rKM+ administered either before or after challenge, exerts a protective effect against
P. brasiliensis infection, with a direct beneficial effect on the lesions severity. Additional
investigations are in progress in order to clarify the whole spectrum of KM+ interference on
experimental PCM. Financial support: FAPESP, CAPES and CNPq.
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Background: Paracoccidioidomycosis (PCM) is a systemic granulomatous disease
caused by Paracoccidioides brasiliensis. It is widespread in South and Central America with
approximately 10 million people possibly infected with this fungus. All patients with
progressive PCM require antifungal treatment chiefly based on sulfamethoxazole-
trimethoprim, amphothericin B and azole-derived drugs. A long-term follow-up is important
in all cases because of the high incidence of relapsing disease. The 15-amino-acid peptide
(P10) from the major 43-kDa diagnostic antigen of P. brasiliensis is protective against
experimental infection in mice. Presently, we analyzed the synergic effect of P10 immunization
and chemotherapy in mice with established pulmonary infection. Methods: Mice were
infected intratracheally with 3x105 yeast cells of virulent P. brasiliensis (Pb18) and were
treated 30 days after infection with the antifungal drug (sulphametoxazole-trimethoprim,
ketoconazole, itraconazole, fluconazole and amphotericin B) for 30 days in association with
peptide P10 immunization. Control groups of infected mice were either treated with drugs,
immunized with peptide only, or did not receive any treatment. Groups of mice were sacrificed
60 and 120 days after infection and colony forming units (CFU) from lung, liver and spleen
were counted. Results: A synergic effect of chemotherapy and P10 immunization was
observed with all drugs tested; a significant reduction of CFU in the lungs of mice was
observed. Antifungal drugs tested separately or P10 immunization alone reduced significantly
the lung CFUs but not as efficiently as with the association protocol. Sulphametoxazole-
trimethoprim treatment resulted in reactivation of the disease at the end of chemotherapy but
not in association with P10 in which case a most effective control of the disease was obtained.
Discussion: Our results showed that: (I) the association of P10 immunization and itraconazole,
fluconazole, or sulphametoxazole-trimethoprim treatment was more effective than the separate
treatment with drugs or immunization; (II) the immunization with P10 (and other peptides
derived from the gp43 and presented by human HLA-DR molecules) in association with
chemotherapy, should be construed as a potential adjuvant therapy of human
paracoccidioidomycosis. Financial support: Supported by FAPESP
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Introduction and Objectives: Paracoccidioides brasiliensis is a human pathogenic
fungus that constitutes a major medical problem in Latin America. The infection is acquired
by either inhalation or percutaneous inoculation of mycelia forms. At tissue temperatures,
the pathogen transforms into a yeast form that parasitizes the intracellular compartment of
macrophages, eliciting chronic, granulomatous inflammation. Yeasts are responsible for
most of the clinical manifestations of PCM. T cell responses are critical for the containment
of the parasite. Little is known about the antigens involved in T cell responses against this
pathogen. Heat shock protein 60 (HSP60), isolated from intracellular fungal, protozoa
and bacterial pathogens have been found to elicit protective immunity in models of infection.
In this study we examined PbHSP60 as a target of T cell mediated immune response to P.
brasiliensis and delineated its activity as a vaccine in experimental PCM during the inductive
and expressive phases of PbHSP60-immune responses. Methods: Groups of BALB/c mice
were immunized by two S.C. injections of 10mg recombinant PbHSP60 or BSA (as a
control). Infection was initiated two weeks later by intranasal inoculation of either 106 or
107 P. brasiliensis yeast cells. In some experiments, CD4+, CD8+ or both subset of T cells
were depleted by I.P. injection of monoclonal antibodies before or after immunization
with PbHSP60. Severity of infection was measured by quantification of fungal burden in
quantitative lung cultures. Results: Vaccination with 10mg of PbHSP60 protected mice
against of P. brasiliensis infection. Elimination of CD4+ cells abolished the protection
conferred by PbHSP60 during the inductive and expressive phase of PbHSP60 immune
responses. Conclusions: PbHSP60 plays a role in protection against experimental PCM
by eliciting a CD4 mediated immune responses. The cytokine profile and the tissue
distribution of HSP60 specific CD4 cells is under investigation. Financial support: CNPq
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Background: Paracoccidioidomycosis (PCM) is a systemic granulomatous disease
caused by Paracoccidioides brasiliensis. It is widespread in South and Central America with
approximately 10 million people possibly infected with this fungus. The 43 kDa glycoprotein
(gp43) is the major diagnostic antigen of PCM, secreted exocellularly by the infective yeast
phase, and recognized by virtually all sera from infected patients using different serological
methods. The biological function of antibodies in PCM is unknown and usually high titers
are associated with the acute form and bad prognosis. In this study, we evaluated the influence
of several monoclonal antibodies (mAb) against gp43 in mice intratracheally infected with a
virulent isolate of Pb 18. Methods: We have analyzed the effect of four anti-gp43 IgG2a
mAbs (32H, 19G, 17D and 10D) and two IgG2b mAbs (3E and 21F). As a control, an
irrelevant mAb (A4) was used. Twenty four hours before the mice were intratracheally infected
with 3x105 yeast cells of Pb18, 1 mg of mAbs was injected intraperitoneally per animal.
Groups of mice were sacrificed 15 and 30 days after the infection and colony forming units
(CFU) from lungs were counted. Results: Significant reduction in the lung CFUs was observed
after 15 days with all mAbs tested with the exception of mAb 32H (IgG2a). However, after
30 days of infection, mAbs 19G and 10D (IgG 2a) and 3E (IgG 2b) were able to control the
disease unlike mAbs 32H and 17D (IgG2a) and 21F (IgG2b) that caused a very significant
increase in the number of lung CFUs. Discussion: Our results showed that some mAbs against
gp43 were able to reduce the CFUs from lungs of infected mice whereas others did not. Even
today, the relationship between Ag-specific antibody protection remains poorly understood
in the majority of fungal dimorphic pathogens causing systemic mycoses. Presently, this
study has been extended to P. brasiliensis. Data suggest that specific Ab responses can have
a role in the immunological protection against PCM. Financial support: FAPESP.
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Introduction and Objectives : The use of DNA vaccine, in experimental stage and
clinical tests can be a major tool to prevent several infections and eliminate them if they are
already established. Previous works demonstrated that a DNA vaccine codifying the
Mycobacterium leprae HSP65 gene cloned into pcDNA3 can prevent infection by
Mycobacterium tuberculosis and have a pronounced therapeutic action. In this context, the
aims of this study are to test this vaccine in mice infected with Paracoccidioides brasiliensis
(Pb) and then to modulate, through the utilization of the DNA-hsp65 vaccine, the cellular
immune response of mice experimentally infected with P.b. Methods and Results : BALB/
C mice were vaccinated three times at two-week intervals with the control vector, pcDNA3 -
HSP65 (100µg). Another control was injection of sacarose only. Mice were challenged (15
days after the third immunization) by intravenous route with 106 cells of Pb18 and sacrificed
after 60 days. Lung fungal burden were counted as colony forming units (C). We found that
vaccination with HSP65-DNA caused CFU decline in lungs compared to both controls.
Histological analyses confirmed these results. Spleen cells proliferation assays, using as stimuli
concanavalin A, showed similar response to non-infected mice. Citokine produced in plasm
and by spleen cells from vaccinated mice are currently being evaluated. Conclusion:
Immunization by intramuscular DNA vaccine protects mice against infection by the virulent
Pb. Therapeutic effects of DNA vaccination against paracoccidiodomycosis are being
investigated. New experiments are being carried out using the pVAX 200-DEST vector,
specifically designed for DNA vaccines. Financial support: CNPq, MCT and FAP-DF.
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Paracoccidioides brasiliensis is the agent of paracoccidioidomycosis, the most systemic
mycosis in Latin America. To date, there is no effective vaccine. Vaccines can be developed
using attenuated pathogens and the ionizing radiation has been used for this purpose since
irradiated pathogens frequently lost its virulence or reproductive ability, but retains its
morphology and metabolism. The aim of this work was to attenuate the yeast form of P.
brasiliensis by gamma irradiation for further studies on vaccine research. P. brasiliensis,
strain Pb-18, were cultured in BHI at 370C. Five-day cultures were irradiated at doses between
0.5 and 10 kGy. After each dose the fungal cells were suspended in PBS, counted, plated and
after 7 days the colony forming units (CFU) counted. The viability of the irradiated cells was
measured using the dye Janus Green and the protein synthesis by incorporation of L-35S
methionine. The proteins secretion was evaluated incubating the cells in a medium without
macromolecules and the protein concentration estimated in the supernatant. The comparison
between the antigenic profile of irradiated and control yeast was made by western blot. The
virulence of the irradiated yeast was analyzed by the inoculation in BALBc mice. After 30
days the organs were removed, homogenized and the suspensions plated. At 6.5 kGy the
yeast lost the reproductive capacity, since no colony forming units were detected in the plating
experiment. The viability and the incorporation of L-35S methionine were the same in control
and up to 6,5 kGy irradiated cells, but 6.5 kGy irradiated yeast secreted 40% less proteins.
The western blot profile was clearly similar in control and 6.5 kGy irradiated yeast indicating
that the irradiated yeast retained the expression of the antigens present in the wild yeast. No
CFU was recovery from the tissues of the mice infected with 6.5 kGy radioattenuated yeast.
We concluded that for P. brasiliensis yeast was possible find a dose in which the pathogen
lost its reproductive ability and virulence, while retains its viability, metabolic activity and
the antigenic profile. Financial support: CDTN/CNEN
